William F. Ebling - Concepedia

Author

William F. Ebling

University at Buffalo, State University of New York

Also Known As

W EBLING, W Ebling, W F Ebling, W. Ebling, W. F. EBLING, W. F. Ebling, W.F. Ebling, W. F. EBLING, W. F. Ebling, William Ebling

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University at Buffalo, State University of New York Stanford University United States Department of Veterans Affairs Stanford Medicine Merck & Co., Inc., Rahway, NJ, USA (United States)

About

William F. Ebling is an author at University at Buffalo, State University of New York specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	873
2	Social Sciences	4	4	209
3	Anesthesia	4	4	257
4	Health Sciences	3	3	167
5	Engineering	1	1	33

William F. Ebling

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena††Supported in part by Grant No. 24211 from the National Institute of General Medical Science, National Institutes of Health. Amarnath Sharma, William F. Ebling, William J. Jusko Journal of Pharmaceutical Sciences	1998	124
From piecewise to full physiologic pharmacokinetic modeling: Applied to thiopental disposition in the rat William F. Ebling, D. Russell Wada, Donald R. Stanski Journal of Pharmacokinetics and Biopharmaceutics Thiopental DispositionPharmacokinetic ModelingPharmacodynamicsPharmacological StudyMedicine	1994	94
Computer Simulation of the Effects of Alterations in Blood Flows and Body Composition on Thiopental Pharmacokinetics in Humans Daisuke Wada, Sven Björkman, William F. Ebling, Anesthesiology	1997	93
Thiopental Pharmacodynamics I. Defining the Pseudo–Steady-state Serum Concentration–EEG Effect Relationship Michael Bührer, P. Maitre, Orlando Hung, Anesthesiology PharmacotherapyThiopental PharmacodynamicsExperimental PharmacologySocial SciencesPharmacodynamic Modeling	1992	92
Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults Stanley J. Szefler, William F. Ebling, John W. Georgitis, European Journal of Clinical Pharmacology Preclinical Drug EvaluationPharmacologyClinical PharmacologyPharmacotherapyMedicine	1986	69
Is It Possible To Estimate the Parameters of the Sigmoid Emax Model with Truncated Data Typical of Clinical Studies? Sandeep Dutta, Yoshiaki Matsumoto, William F. Ebling Journal of Pharmaceutical Sciences	1996	68
The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: The reversible metabolism of methylprednisolone and methylprednisone in rabbits William F. Ebling, William J. Jusko Journal of Pharmacokinetics and Biopharmaceutics Animal PhysiologyEnergy MetabolismBody CompositionBiochemistryMedicine	1986	68
Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate William F. Ebling, Stanley J. Szefler, William J. Jusko Journal of Chromatography B Biomedical Sciences and Applications Adrenal GlandStress HormonePsychiatryMedicineMethylprednisolone Hemisuccinate	1984	67
Formulation-dependent Pharmacokinetics and Pharmacodynamics of Propofol in Rats Sandeep Dutta, William F. Ebling Journal of Pharmacy and Pharmacology	1998	66
Quantitation of Depth of Thiopental Anesthesia in the Rat Lars L. Gustafsson, William F. Ebling, Eileen Osaki, Anesthesiology	1996	62

Page 1